Bio-Path Holdings, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Houston TX United States (2011)

Organization Overview

First Clinical Trial
2011
NCT01159028
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Bio-Path Holdings, Inc.